{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-023518","form_type":"8-K","ticker":"TELA","cik":"0001561921","company_name":"TELA Bio, Inc.","filed_at":"2023-02-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.584535+00:00","generated_at":"2026-06-19T06:54:44.612528+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"TELA Bio launches two larger OviTex LPR configurations for large abdominal hernia repair","bullets":["New 15x20 cm and 15x25 cm ellipse sizes for ventral and incisional hernias.","Designed for robotic and laparoscopic ports; low profile facilitates minimally invasive placement.","In prior quarter, 40% of OviTex cases were robotic and 20% laparoscopic.","OviTex LPR initially commercialized in 2018; new sizes expand product portfolio."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-023518","json":"https://secwatch.observer/filing/0001104659-23-023518.json","markdown":"https://secwatch.observer/filing/0001104659-23-023518.md","text":"https://secwatch.observer/filing/0001104659-23-023518.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1561921/000110465923023518/0001104659-23-023518-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1561921/000110465923023518/tm237356d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T06:54:44.612528+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}